Automated diagnostic support system with deep learning algorithms for distinction of Philadelphia chromosome-negative myeloproliferative neoplasms using peripheral blood specimen
Open Access
- 9 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-11
- https://doi.org/10.1038/s41598-021-82826-9
Abstract
Philadelphia chromosome-negative myeloproliferative neoplasms (Ph-negative MPNs) such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis are characterized by abnormal proliferation of mature bone marrow cell lineages. Since various non-hematologic disorders can also cause leukocytosis, thrombocytosis and polycythemia, the detection of abnormal peripheral blood cells is essential for the diagnostic screening of Ph-negative MPNs. We sought to develop an automated diagnostic support system of Ph-negative MPNs. Our strategy was to combine the complete blood cell count and research parameters obtained by an automated hematology analyzer (Sysmex XN-9000) with morphological parameters that were extracted using a convolutional neural network deep learning system equipped with an Extreme Gradient Boosting (XGBoost)-based decision-making algorithm. The developed system showed promising performance in the differentiation of PV, ET, and MF with high accuracy when compared with those of the human diagnoses, namely: > 90% sensitivity and > 90% specificity. The calculated area under the curve of the ROC curves were 0.990, 0.967, and 0.974 for PV, ET, MF, respectively. This study is a step toward establishing a universal automated diagnostic system for all types of hematology disorders.Funding Information
- Grants-in Aid for Scientific Research (20K20230, 18K07424)
- International Joint Research Programs (19KK0221)
This publication has 14 references indexed in Scilit:
- An application of machine learning to haematological diagnosisScientific Reports, 2018
- Myeloproliferative neoplasms: from origins to outcomesBlood, 2017
- NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018Journal of the National Comprehensive Cancer Network, 2017
- European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemiaAmerican Journal of Hematology, 2017
- Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis.American Journal of Clinical Pathology, 2017
- Myeloproliferative neoplasms: A decade of discoveries and treatment advancesAmerican Journal of Hematology, 2015
- Performance evaluation of the Sysmex haematology XN modular systemJournal of Clinical Pathology, 2012
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- European consensus on grading bone marrow fibrosis and assessment of cellularity.2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005